Work for Sol-Gel Technologies Ltd.?

Claim Your Profile

Sol-Gel Technologies Ltd. Logo Image

Sol-Gel Technologies Ltd.

About Sol-Gel Technologies Ltd.

11-50 Employees
Based in Ness Ziona, Israel

Sol-Gel is a clinical-stage specialty pharmaceutical company focused on developing and commercializing topical dermatological drug products. Their lead product candidates, VERED for the treatment of papulopustular rosacea and TWIN and SIRS-T for the treatment of acne vulgaris (“acne”) are based upon their proprietary microencapsulation delivery system. This technology consists of microcapsules made of silica. Based on their pre-clinical and clinical data, this delivery system should enable them to develop and commercialize dermatological drug products that are more effective and/or have fewer side effects than currently marketed drugs.

NASDAQ (See More NASDAQ Companies)
Biotechnology (See More Biotechnology Companies)
Healthcare (See More Healthcare Companies)

Looking for Other Annual Reports?

Search by company name or ticker symbol